Amgen (AMGN)
(Real Time Quote from BATS)
$270.71 USD
-0.16 (-0.06%)
Updated Dec 6, 2023 02:56 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Price, Consensus and EPS Surprise
AMGN 270.71 -0.16(-0.06%)
Will AMGN be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMGN
3 Top Dividend Stocks to Maximize Your Retirement Income
Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is BioMarin (BMRN) Up 14.3% Since Last Earnings Report?
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Amgen (AMGN) Up 2.2% Since Last Earnings Report: Can It Continue?
Other News for AMGN
30 Stocks shunned by hedge and mutual funds - GS
Top 30 stocks with highest hedge fund + mutual fund short positions – GS
Top stocks with highest hedge fund + mutual fund positions, according to GS
P/E Ratio Insights for Amgen
Amgen Inc. stock underperforms Tuesday when compared to competitors